meeting four

TRANSCRIPT: Meeting 4, Concluding Remarks

DR. GUTMANN:
Let me just say thank you to all of our speakers, all the members of the public who participated in this. You have shared your time, your energy, your expertise and we have received a lot of valuable comments.

Date

Tue, 03/01/2011

TRANSCRIPT: Meeting 4, Session 8

DR. WAGNER:
Okay. Good morning, everyone. Welcome back to this session.

Let me announce for those in the audience that we have set aside 45 minutes or so for comment, beginning at 12:35. So what we will do is go through this panel and then we will have a roundtable discussion without audience input. Okay? But please do write down or remember your questions for that session that will begin at 12:35 where we will focus on audience interest.

Date

Tue, 03/01/2011

TRANSCRIPT: Meeting 4, Session 7

DR. WAGNER:
Thanks, Amy. And thanks so much for that background, Val. We appreciate the report you received.

Date

Tue, 03/01/2011

TRANSCRIPT: Meeting 4, Opening Remarks & Executive Director's Report

DR. GUTMANN:
Good morning everybody. I’m Amy Gutmann, President of the University of Pennsylvania and Chair of the Presidential Commission for the Study of Bioethical Issues. On behalf of myself and Vice Chair Jim Wagner, who is President of Emory University, I would like to welcome you to day two of our Fourth Meeting here in the nation’s capital.

Date

Tue, 03/01/2011

TRANSCRIPT: Meeting 4, Closing Remarks

DR. GUTMANN:
Let me just say a few words in conclusion. One is that we invite anybody to -- people who have presented, people in the audience, any member of the concerned public -- to write us, and we have a website with the information, if you have any comments, or any suggestions for us.

Date

Mon, 02/28/2011

TRANSCRIPT: Meeting 4, Session 6

DR. GUTMANN:
Hank, thank you. I’m going to ask all of our presenters to help us on a specific question that we ourselves, are going to be asking and answering, over the next week or so, and that is, what we, as a Commission, on the broad subject area of genetic and neuroimaging and its ethical implications and the social responsibility attached to that, what can we most productively take on, as a Commission?
 
So, what I’m going to do is really go around, not ask the Commission members, but the presenters, a very pointed question.
 

Date

Mon, 02/28/2011

TRANSCRIPT: Meeting 4, Session 5

DR. GUTMANN:
We are going to get started. So, if the people back there can come up and take a seat, I would appreciate it. Thank you. There you go. Thank you very much.
 

So, we are going to be discussing, again, and with our three experts at the table, some of the current issues in neuroscience and neuroimaging.

Date

Mon, 02/28/2011

Pages

Subscribe to RSS - meeting four